AzTrials
AzTrials

StrokeNCT07087743

Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab

A study testing VR-Based Gait Training with End-Effector Robot in people with Stroke and Robot Assisted Gait Training, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study evaluates a novel Virtual Reality (VR)-integrated visual feedback system designed to enhance limb propulsion during robot-assisted gait rehabilitation in individuals post-stroke. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
What is being tested?
VR-Based Gait Training with End-Effector Robot
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
25 Jul 2025to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 20 years or older.
  • For post-stroke participants:
  • Diagnosis of stroke at least 1 month prior to participation.
  • Able to walk at least 10 meters with or without assistive devices.
  • For healthy participants:
  • ° Must walk independently without assistive devices.

Who cannot join

  • Individuals with a life expectancy of less than one year.
  • Comatose individuals.
  • Individuals unable to follow three-step commands.
  • Individuals with lower limb amputation.
  • Individuals with poorly controlled diabetes (e.g., foot ulceration).
  • Individuals with legal blindness.
Show all 12Show fewer
  • Individuals with progressive neurological conditions.
  • Medically unstable individuals.
  • Individuals with significant musculoskeletal impairments.
  • Individuals with congestive heart failure or unstable angina.
  • Individuals with peripheral vascular disease.
  • Individuals with severe neuropsychiatric disorders (e.g., dementia, cognitive deficits, or severe depression).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mansoo Ko, PhD contact

409-747-1617

mako@utmb.edu

United States1 site, 1 recruiting
  • University of Texas Medical Branch

    Galveston, Texas, 77555

    Mansoo Ko, 409-747-1617

    Recruiting

Other trials in United States

About this study

Official title: Virtual Reality-Integrated Limb Propulsion Visual Feedback System for End-Effector Robot-Assisted Stroke Rehabilitation

This study evaluates a novel Virtual Reality (VR)-integrated visual feedback system designed to enhance limb propulsion during robot-assisted gait rehabilitation in individuals post-stroke. In collaboration with CUREXO, a rehabilitation robotics company, the system is embedded within the Morning Walk® end-effector robot and provides real-time visual feedback to facilitate symmetrical use of the paretic and non-paretic limbs. The goal is to address gait asymmetry commonly observed in hemiparetic stroke survivors by promoting improved paretic leg propulsion, which is a key contributor to forward movement during walking.

A total of 30 participants (15 stroke, 15 healthy controls) aged 20 years or older will undergo single-session gait training using the VR-robot system. Participants will be assessed using spatiotemporal gait parameters, muscle activity, foot pressure, and vertical ground reaction forces. Additional safety measures-including a saddle-type weight support and real-time heart rate monitoring via smartwatch-are implemented to ensure a safe and controlled training environment. This study aims to test the feasibility and effectiveness of this VR-based system in improving gait symmetry and functional walking capacity in people recovering from stroke.

Read the detailed description

Introduction and Purpose:

People with hemiparetic stroke often exhibit gait asymmetry due to reduced propulsion from the paretic leg. This contributes to overreliance on the non-paretic leg and leads to inefficient, energy-consuming walking patterns. Traditional rehabilitation, including robot-assisted gait training, typically emphasizes repetitive motion but lacks a specific focus on propulsion, limiting its potential to promote neuroplasticity and symmetrical gait.

To address this limitation, the research team has developed a Virtual Reality (VR)-based visual feedback system that delivers real-time, individualized cues aimed at improving paretic limb propulsion. This system is integrated into the Morning Walk® end-effector rehabilitation robot developed by CUREXO. By encouraging active use of the paretic limb, the intervention is designed to reduce compensatory movement strategies and improve gait symmetry.

Study Objectives:

The primary objective is to evaluate the feasibility and effectiveness of this VR-enhanced limb propulsion training system. The study compares spatiotemporal gait parameters between individuals post-stroke and healthy controls, with the goal of determining whether real-time visual feedback can improve bilateral coordination and reduce asymmetry.

Participants:

A total of 30 participants (15 post-stroke, 15 healthy) aged 20 years or older will be recruited. Stroke participants must have experienced a stroke at least one month prior to enrollment and be able to walk at least 10 meters with or without assistive devices. Healthy controls must walk independently without assistance.

Methods:

Each participant will complete a single-session gait training protocol with pre- and post-assessments. Equipment used includes:

Zeno Walkway: Overground gait mat to assess spatiotemporal gait parameters before and after training.

Morning Walk® Robot: End-effector rehabilitation device with integrated VR propulsion visual feedback system.

Delsys EMG Sensors: For analysis of bilateral lower extremity muscle activity.

Tekscan In-Shoe Sensors: To measure ground reaction forces and foot pressure during walking.

Smartwatch Monitoring: To track heart rate during training as an indicator of exertion (data not stored or transmitted).

Procedures:

Baseline Assessments: Collection of demographic data, health history, physical function, height, and weight.

Pre-Training Gait Assessment: Overground walking trials using the Zeno Walkway.

VR Robot Gait Training: Participants walk with the Morning Walk® robot while receiving propulsion-related visual feedback in VR.

Post-Training Gait Assessment: Re-evaluation using the Zeno Walkway to assess changes in gait performance.

Data Collection:

Real-time biomechanical data (spatiotemporal parameters, EMG, and foot pressure/GRFs) will be collected and analyzed. Smartwatch data will only be viewed during the session and will not be stored.

Risks and Safety:

Risks are minimal. The Morning Walk® robot features a saddle-type support system and protective surrounds to prevent falls. Minor skin irritation may occur from EMG electrodes. All data will be stored securely on password-protected devices.

Significance:

This study is the first to integrate a VR-based propulsion feedback system into an end-effector gait training robot. It is expected to enhance paretic limb engagement, promote symmetrical gait patterns, and support motor learning through individualized feedback and neuroplastic adaptation.

Being tested
VR-Based Gait Training with End-Effector Robot
Keywords
Propulsion Feedback, Gait Rehabilitation, Paretic Leg, Virtual Reality, End-Effector Robot
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR-Based Gait Training with End-Effector RobotBehavioural

    A single-session gait training protocol using the Morning Walk® end-effector robot with real-time virtual reality visual feedback to encourage paretic limb propulsion and symmetrical gait. This intervention is intended to study participants' behavioral and biomechanical responses to the VR feedback, not to evaluate the robot as a device.

Study groups in NCT07087743
Study groupRoleWhat they receive
Post-Stroke GroupExperimentalIndividuals who have had a stroke will complete a single session of VR-integrated gait training using the Morning Walk® end-effector robot. Gait performance will be evaluated before and after training.
Receives: Behavioral: VR-Based Gait Training with End-Effector Robot
Healthy GroupExperimentalHealthy participants will undergo the same single-session VR-integrated gait training using the Morning Walk® end-effector robot. Pre- and post-training assessments will be conducted.
Receives: Behavioral: VR-Based Gait Training with End-Effector Robot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Spatiotemporal Gait Symmetry using the Zeno Walkway GaitMat

    Spatiotemporal gait parameters will be collected using the Zeno Walkway GaitMat before and after a single session of VR-based gait training. Gait spatiotemporal parameters will be calculated from the ratio of step lengths (paretic/non-paretic in stroke group; left/right in healthy group). The step length will be compared pre- and post-training.

    Measured: Baseline (pre-training) and immediately post-training (same session)

Secondary outcomes (2)
  1. Change in Peak Propulsive Force (Paretic vs. Non-Paretic Limb)

    Ground reaction forces and foot pressure data will be collected using the Tekscan In-Shoe system during walking trials. Ground reaction force from each foot will be compared pre- and post-training

    Measured: Baseline and immediately post-training (same session)

  2. Change in Lower Extremity Muscle Activity

    Bilateral lower extremity muscle activity (e.g., tibialis anterior, soleus) will be recorded using Delsys wireless EMG sensors. EMG data during walking will be analyzed to detect neuromuscular adaptation after VR-based gait training.

    Measured: Baseline and immediately post-training (same session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start25 Jul 2025
  3. Primary completion27 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
This is a mixed design study with two distinct populations: individuals post-stroke and healthy controls. All participants undergo a single session of VR-based gait training with an end-effector robot. Pre- and post-intervention measures are collected to evaluate within-subject changes and between-group differences.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07087743
Sponsor's protocol ID
25-0065
Status last verified
Mar 2026
First submitted
9 Jul 2025
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR-Based Gait Training with End-Effector Robot in people with Stroke and Robot Assisted Gait Training, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mansoo Ko, PhD (409-747-1617, mako@utmb.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Spatiotemporal Gait Symmetry using the Zeno Walkway GaitMat (time frame: Baseline (pre-training) and immediately post-training (same session)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in